Malignant tumor formation is driven by aberrations in signaling pathways controlling cellular growth, proliferation and death. A large next-generation sequencing (NGS) panel which includes not just the well known genes in these pathways but also the lesser studied members offers a more comprehensive assessment of the involvement of these pathways. We thus aimed to profile the samples analyzed at our facility over the last 5 years to characterize their cancer signaling pathways.